Lung cancer is the second most common cancer in men and women and is the leading cause of cancer-related death. The American Cancer Society estimates that approximately 236,740 new cases of lung cancer (117,910 in men and 118,830 in women) will be diagnosed in 2022 and approximately 130,180 individuals (68,820 men and 61,360 women) will die from the disease. In the United States, the number of new lung cancer cases in men has been declining annually since the mid-1980s. In women, the number of new cases diagnosed each year started declining in the mid-2000s. Between 2009 and 2018, incidence rates dropped 1.4% each year in women compared with 2.8% each year in men. How much do you know about lung cancer?
Cancer that originates in the liver is known as primary liver cancer. According to the American Cancer Society, approximately 41,260 individuals (28,600 men and 12,660 women) will be diagnosed with primary liver cancer in the United States in 2022, and approximately 30,520 individuals (20,420 men and 10,100 women) will die from the disease. From 1980 to 2015, incidence rates for primary liver cancer have more than tripled, although these rates have stabilized recently, and between 1980 and 2013, the overall liver cancer death rate has more than doubled. How much do you know about primary liver cancer?
Aside from nonmelanoma skin cancer, prostate cancer is the most common cancer diagnosed among men in the United States and the second leading cause of death in American men. Most prostate cancers are adenocarcinomas, which begin in the gland cells (the cells that make secretions). In rare cases, other types of cancer develop in the prostate, including small-cell carcinomas, transitional-cell carcinomas, neuroendocrine tumors, and sarcomas. According to the American Cancer Society, approximately 268,490 men will be diagnosed with prostate cancer in the United States, and approximately 34,500 men will die from the disease. How much do you know about prostate cancer?
Approximately 3.4 million Americans will be diagnosed with skin cancer in 2022, making it the most common form of cancer in the United States. Included in this estimation are patients with basal-cell carcinoma and squamous-cell carcinoma, which are the most common types of skin cancer, as well as patients with melanoma, which accounts for approximately 1% of all skin cancers, but is responsible for a large majority of skin cancer–related deaths. Although the total number and incidence rates of basal-cell carcinoma and squamous-cell carcinoma cannot be precisely determined because reporting to cancer registries is not required, it is estimated that they account for less than 0.1% of patient deaths caused by cancer. However, the American Cancer Society estimates that approximately 99,780 individuals will be diagnosed with melanoma in 2022, and approximately 7650 individuals will die from the disease. How much do you know about skin cancer?
Soft tissue sarcoma is a rare form of cancer that begins in tissues that connect or support other structures in the body, such as fat, muscle, nerves, fibrous tissues, blood vessels, or deep skin tissues. Although the majority of soft tissue sarcomas originate in the arms or legs, they can also be found in internal organs or the retroperitoneum, the trunk, or the head and neck area. Soft tissue sarcomas are most commonly diagnosed in children, accounting for approximately 15% of all pediatric cancers. According to the American Cancer Society, approximately 13,190 individuals (7590 men and 5600 women) will be diagnosed with soft tissue sarcomas in the United States in 2022, and approximately 5130 individuals (2740 men and 2390 women) will die from the disease. How much do you know about soft tissue sarcomas?
On June 5, 2022, people around the world will celebrate National Cancer Survivors Day®, a time set aside to recognize cancer survivors, raise awareness of the ongoing challenges these individuals face because of their disease, and celebrate life. A cancer survivor can be defined as anyone who has a history of cancer, from diagnosis through treatment and the remainder of life. The American Cancer Society, the National Cancer Institute, and many other organizations focus a great deal of their efforts on helping cancer survivors manage any ongoing physical, psychosocial, and functional problems related to their disease and treatments, and promoting cancer survivor health and quality of life. How much do you know about cancer survivorship?
Brain and spinal cord tumors are rare forms of cancer, accounting for approximately 1.3% of all new cancer cases in the United States. The lifetime risk for being diagnosed with a malignant tumor of the brain or spinal cord is <1%. According to the American Cancer Society, approximately 25,050 individuals (14,170 men and 10,880 women) will be diagnosed with malignant tumors of the brain or spinal cord in 2022, and approximately 18,280 individuals (10,170 men and 7570 women) will die from the disease. The overall 5-year survival rate for brain and spinal cord tumors is approximately 36%; 75% for individuals aged <15 years; 72% for individuals aged 15 to 39 years; and 21% for individuals aged >40 years. How much do you know about brain and spinal cord tumors?
Testicular cancer is a malignancy that most commonly originates in the germ cells of 1 or both of the testicles. Although rare, testicular cancer is one of the most frequently diagnosed cancers in young adult men between the ages of 30 and 39 years. For reasons that have yet to be identified, the incidence rates for testicular cancer has been on the rise for the past several decades, although this increase in rates has slowed in recent years. According to the American Cancer Society, approximately 9910 men in the United States will be diagnosed with testicular cancer in 2022, and approximately 460 will die from the disease. How much do you know about testicular cancer?
Kidney cancer, also known as renal cancer, is one of the top 10 most common cancers in both men and women in the United States. According to the American Cancer Society, approximately 79,000 individuals (50,290 men and 28,710 women) will be diagnosed with kidney cancer in 2022, and approximately 13,920 individuals (8960 men and 4960 women) will die from the disease. Kidney cancer is most frequently diagnosed in individuals aged 65 to 74 years, and is uncommon in those younger than 45 years. The incidence of kidney cancer has been increasing for several decades, although this uptick in cases has slowed in recent years. Although experts are not certain what is causing this rise in incidence, many believe that is can be attributed in part to the use more effective scanning techniques, which can detect the disease at an earlier stage. How much do you know about kidney cancer?
Bladder cancer is the sixth most common cancer diagnosed in the United States. It is the fourth most common cancer in men and the twelfth most common cancer in women. According to the American Cancer Society, approximately 81,180 new cases of bladder cancer (61,700 men and 19,480 women) will be diagnosed in the United States in 2022, and approximately 17,100 individuals (12,120 men and 4980 women) will die from the disease. How much do you know about bladder cancer?
Page 1 of 7
Results 1 - 10 of 62
Results 1 - 10 of 62